Literature DB >> 18838692

Coordinate regulation of enzyme markers for inflammation and for protection against oxidants and electrophiles.

Hua Liu1, Albena T Dinkova-Kostova, Paul Talalay.   

Abstract

An elaborate network of highly inducible phase 2 proteins protects aerobic cells against the cumulative damaging effects of reactive oxygen intermediates and toxic electrophiles, which are the major causes of malignancy and chronic degenerative diseases. Many chemical and phytochemical agents, all of which react with thiol groups, induce the phase 2 response through their reactivity with critical cysteine thiols of Keap1. We recently found that the anti-inflammatory potencies (suppression of iNOS and COX-2 expression) of a series of triterpenoids with Michael reaction centers were closely correlated with the potencies of these agents to induce the phase 2 response. We now report that representatives of seven recognized chemical classes of inducers, including isothiocyanates, bisbenzylidenes, arsenicals, heavy metals, and vicinal dithiols, showed highly correlated inducer and anti-inflammatory potencies spanning more than six orders of magnitude of concentrations in established cells and in primary mouse peritoneal macrophages. Potency measurements were expressed as the D(m) values (median effect concentration) by use of the Median Effect Equation. Whereas the phase 2 induction required the functional integrity of both the repressor Keap1 and the transcription factor Nrf2, the effectiveness of inducers in blocking the up-regulation of iNOS by inflammatory cytokines was related to the nature of the cytokine and the inducer concentration. These studies identify suppression of inflammation as a consistent property of inducers of the phase 2 response and strongly suggest that this property is a central aspect of their chemoprotective actions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18838692      PMCID: PMC2572965          DOI: 10.1073/pnas.0808346105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

Review 1.  Induction of quinone reductase as a primary screen for natural product anticarcinogens.

Authors:  Young-Hwa Kang; John M Pezzuto
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

Review 2.  The "Prochaska" microtiter plate bioassay for inducers of NQO1.

Authors:  Jed W Fahey; Albena T Dinkova-Kostova; Katherine K Stephenson; Paul Talalay
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

Review 3.  Direct and indirect antioxidant properties of inducers of cytoprotective proteins.

Authors:  Albena T Dinkova-Kostova; Paul Talalay
Journal:  Mol Nutr Food Res       Date:  2008-06       Impact factor: 5.914

4.  Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: the indirect antioxidant effects of sulforaphane.

Authors:  X Gao; A T Dinkova-Kostova; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

5.  Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms.

Authors:  E Heiss; C Herhaus; K Klimo; H Bartsch; C Gerhäuser
Journal:  J Biol Chem       Date:  2001-06-15       Impact factor: 5.157

6.  Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound.

Authors:  Susanne Braun; Christine Hanselmann; Marcus G Gassmann; Ulrich auf dem Keller; Christiane Born-Berclaz; Kaimin Chan; Yuet Wai Kan; Sabine Werner
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

7.  Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2).

Authors:  Ken Itoh; Mie Mochizuki; Yukio Ishii; Tetsuro Ishii; Takahiro Shibata; Yoshiyuki Kawamoto; Vincent Kelly; Kiyohisa Sekizawa; Koji Uchida; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

8.  Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers.

Authors:  Nobunao Wakabayashi; Albena T Dinkova-Kostova; W David Holtzclaw; Moon-Il Kang; Akira Kobayashi; Masayuki Yamamoto; Thomas W Kensler; Paul Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-05       Impact factor: 11.205

9.  Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells.

Authors:  Tomomi Kitamuro; Kazuhiro Takahashi; Kazuhiro Ogawa; Reiko Udono-Fujimori; Kazuhisa Takeda; Kazumichi Furuyama; Masaharu Nakayama; Jiying Sun; Hiroyoshi Fujita; Wataru Hida; Toshio Hattori; Kunio Shirato; Kazuhiko Igarashi; Shigeki Shibahara
Journal:  J Biol Chem       Date:  2003-01-02       Impact factor: 5.157

10.  Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants.

Authors:  Albena T Dinkova-Kostova; W David Holtzclaw; Robert N Cole; Ken Itoh; Nobunao Wakabayashi; Yasutake Katoh; Masayuki Yamamoto; Paul Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

View more
  42 in total

1.  Actin cytoskeleton remodeling by the alternatively spliced isoform of PDLIM4/RIL protein.

Authors:  Olga A Guryanova; Judith A Drazba; Elena I Frolova; Peter M Chumakov
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  Screening for natural chemoprevention agents that modify human Keap1.

Authors:  Chenqi Hu; Dejan Nikolic; Aimee L Eggler; Andrew D Mesecar; Richard B van Breemen
Journal:  Anal Biochem       Date:  2011-10-22       Impact factor: 3.365

Review 3.  Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis.

Authors:  Joydeb Kumar Kundu; Young-Joon Surh
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

Review 4.  Nrf2: a potential target for new therapeutics in liver disease.

Authors:  A M Bataille; J E Manautou
Journal:  Clin Pharmacol Ther       Date:  2012-08-08       Impact factor: 6.875

Review 5.  Nuclear factor-erythroid 2-related factor 2 as a chemopreventive target in colorectal cancer.

Authors:  Constance Lay Lay Saw; Ah-Ng Tony Kong
Journal:  Expert Opin Ther Targets       Date:  2011-01-25       Impact factor: 6.902

6.  The tobacco smoke component, acrolein, suppresses innate macrophage responses by direct alkylation of c-Jun N-terminal kinase.

Authors:  Milena Hristova; Page C Spiess; David I Kasahara; Matthew J Randall; Bin Deng; Albert van der Vliet
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

Review 7.  Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.

Authors:  Vittorio Calabrese; Carolin Cornelius; Albena T Dinkova-Kostova; Edward J Calabrese; Mark P Mattson
Journal:  Antioxid Redox Signal       Date:  2010-08-28       Impact factor: 8.401

8.  Potency ranking of triterpenoids as inducers of a cytoprotective enzyme and as inhibitors of a cellular inflammatory response via their electron affinity and their electrophilicity index.

Authors:  René V Bensasson; Vincent Zoete; Gaston Berthier; Paul Talalay; Albena T Dinkova-Kostova
Journal:  Chem Biol Interact       Date:  2010-04-28       Impact factor: 5.192

9.  Electrophilic tuning of the chemoprotective natural product sulforaphane.

Authors:  Young-Hoon Ahn; Yousang Hwang; Hua Liu; Xiu Jun Wang; Ying Zhang; Katherine K Stephenson; Tatiana N Boronina; Robert N Cole; Albena T Dinkova-Kostova; Paul Talalay; Philip A Cole
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

Review 10.  Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2.

Authors:  Qiang Ma; Xiaoqing He
Journal:  Pharmacol Rev       Date:  2012-09-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.